Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
Clinical trial NCT03772353 · UNKNOWN
Trial details
- NCT number
- NCT03772353
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-12
- Primary completion
- 2023-06-10
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.